SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:umu-83887"
 

Search: onr:"swepub:oai:DiVA.org:umu-83887" > Association Between...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Association Between Circulating Endostatin, Hypertension Duration, and Hypertensive Target-Organ Damage

Carlsson, Axel C (author)
Karolinska Institutet,Uppsala universitet,Geriatrik,Molekylär epidemiologi,Science for Life Laboratory, SciLifeLab
Ruge, Toralph (author)
Uppsala universitet,Umeå universitet,Kirurgi,Geriatrik
Sundström, Johan (author)
Uppsala universitet,Kardiovaskulär epidemiologi
show more...
Ingelsson, Erik (author)
Uppsala universitet,Molekylär epidemiologi,Science for Life Laboratory, SciLifeLab
Larsson, Anders (author)
Uppsala universitet,Biokemisk struktur och funktion
Lind, Lars (author)
Uppsala universitet,Kardiovaskulär epidemiologi
Ärnlöv, Johan, 1970- (author)
Uppsala universitet,Högskolan Dalarna,Medicinsk vetenskap,Geriatrik,Molekylär epidemiologi,Science for Life Laboratory, SciLifeLab
show less...
 (creator_code:org_t)
Lippincott Williams & Wilkins, 2013
2013
English.
In: Hypertension. - : Lippincott Williams & Wilkins. - 0194-911X .- 1524-4563. ; 62:6, s. 1146-1151
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Our aim is to study associations between circulating endostatin, hypertension duration, and hypertensive target-organ damage. Long-term hypertension induces cardiovascular and renal remodeling. Circulating endostatin, a biologically active derivate of collagen XVIII, has been suggested to be a relevant marker for extracellular matrix turnover and remodeling in various diseases. However, the role of endostatin in hypertension and hypertensive target-organ damage is unclear. Serum endostatin was measured in 2 independent community-based cohorts: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS; women 51%; n=812; mean age, 75 years) and the Uppsala Longitudinal Study of Adult Men (ULSAM; n=785; mean age, 77.6 years). Retrospective data on blood pressure measurements and antihypertensive medication (PIVUS >5 years, ULSAM >27 years), and cross-sectional data on echocardiographic left ventricular mass, endothelial function (endothelium-dependent vasodilation assessed by the invasive forearm model), and urinary albumin/creatinine ratio were available. In PIVUS, participants with 5 years of history of hypertension portrayed 0.42 SD (95% confidence interval, 0.23-0.61; P<0.001) higher serum endostatin, compared with that of normotensives. This association was replicated in ULSAM, in which participants with 27 years hypertension duration had the highest endostatin (0.57 SD higher; 95% confidence interval, 0.35-0.80; P<0.001). In addition, higher endostatin was associated with higher left ventricular mass, worsened endothelial function, and higher urinary albumin/creatinine ratio (P<0.03 for all) in participants with prevalent hypertension. Circulating endostatin is associated with the duration of hypertension, and vascular, myocardial, and renal indices of hypertensive target-organ damage. Further studies are warranted to assess the prognostic role of endostatin in individuals with hypertension.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)

Keyword

angiogenesis effects
antiangiogenesis effects
cohort study
endothelial cells
epidemiology
extracellular matrix
Sweden
vascular stiffness
Hälsa och välfärd

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view